Loading Events
Find Events

Event Views Navigation

Upcoming Events › Grant

Events List Navigation

October 2017

Cycle 3: NIH Academic Research Enhancement Award (R15)

October 25

Sponsor: NIH
Due Date: October 25, 2017
Award: Direct costs limited to $300,000 over a maximum of 3 years.

Find out more »

Assessment of Prevention, Diagnosis, and Treatment Options

October 31

Sponsor: Patient-Centered Outcomes Research Institute
LOI Due Date: October 31, 2017
Application Due Date: February 6, 2018
Award: Research Award. Past cycle had direct costs of $2 million.

Find out more »

Cycle 3: Pragmatic Clinical Studies to Evaluate Patient-Centered Outcomes

October 31

Sponsor: Patient-Centered Outcomes Research Institute (PCORI)
LOI Due Date: October 31, 2017
Application Due Date: February 6, 2018
Award: Research Award. Previous cycles had direct costs of $10 million.

Find out more »
November 2017

Cycle 2: W.M. Keck Foundation Grant Program

November 1

Sponsor: W.M. Keck Foundation
Phase 1 Due Date: November 1, 2017
Full Proposal Due Date: February 15, 2018
Award: Historically, grants range from $500,000 to $5 million and are typically $2 million or less

Find out more »

American Fellowships: Summer/Short-Term Research Publication Grants

November 15

Sponsor: American Association of University Women Educational Foundation
Due Date: Nov. 15 annually
Award: $6,000 is available for an eight-week grant period.

Find out more »

Cycle 4: Alzheimer’s Drug Discovery Foundation

November 17

LOI DUE NOVEMBER 17, 2017
Preclinical Drug Discovery
Seeks to fund promising preclinical drug discovery and biomarker development programs for Alzheimer’s disease, related dementias and cognitive aging. The ADDF typically supports one year of research at a time, with potential for future follow-on funding. Funding can range from $150,000-$600,000 for a preclinical project.
Program to Accelerate Clinical Trials (PACT)
Seeks to fund biomarker-based, proof-of-concept pilot clinical trials, as well as Phase 1 safety testing and IND-enabling studies to accelerate new drugs into trials. Up to $1.5 million.
Biomarkers Development
Seeks to support the development and validation of novel and existing biomarkers that will enhance the design and performance of clinical trials for Alzheimer’s disease, related dementias, and cognitive aging. $150,000-$300,000/year, 1-2 years.
Prevention Beyond the Pipeline
The ADDF seeks to support prevention drug discovery not covered by most research funders or our current RFPs. Funding can range from $50,000-$100,000 for epidemiological analyses, $150,000-$600,000 for preclinical research, and up to $1.5 million for clinical trials.

Find out more »
December 2017

Cycle 3: Ruth L. Kirschstein National Research Service Awards (F Series)

December 8

Sponsor: National Institutes of Health
Due Date: December 8, 2017 by 5 pm local time of applicant organization
Award: Fellowship

Find out more »

Cycle 3: Conference Grants (R13) and Conference Cooperative Agreements (U13)

December 12

Sponsor: NIH
Due Date: December 12, 2017
Award: Funding for conferences

Find out more »

AAUW Career Development Grants

December 15

Sponsor: American Association of University Women Educational Foundation
Due Date: December 15, 2017
Award: $2,000–12,000

Find out more »
January 2018

ANGEL (Advanced Neurotherapeutic Grant of Excellence) Award

January 1, 2018

Sponsor: International Rett Syndrome Foundation (IRSF)
Due Date: Applications accepted on a rolling basis
Award: Up to $600,000 over two years

Find out more »

The Biomarkers Consortium

January 1, 2018

Sponsor: Foundation for the National Institutes of Health
Due Date: Rolling basis
Award: If a project idea is approved for further development and implementation, the Foundation for the National Institutes of Health will seek funding to support the resulting project and manage its execution.

Find out more »

Community Action Grants

January 1, 2018

Sponsor: American Association of University Women
Due Date: January 15 annually
Award: $5,000-$7,000 one-year grant; $5,000-10,000 two-year grant

Find out more »

Rolling Basis: Alzheimer’s Drug Discovery Foundation

January 1, 2018

PROPOSALS ACCEPTED ON A ROLLING BASIS
ADDF/NIH
Supports NIA and NINDS grant proposals in NIH format that were scored but not funded, which fall within our mission and research priorities.
Conference Funding
ADDF supports scientific conferences that are relevant to our mission with grants up to $10,000.

Find out more »

Cycle 2: BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44)

January 5, 2018

Sponsor: National Institutes of Health
Due Date: January 5, 2018 by 5 pm local time of applicant
Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Find out more »

Cycle 2: BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR)(R41/R42)

January 5, 2018

Sponsor: National Institutes of Health
Due Date: January 5, 2018 by 5 pm local time of applicant
Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Find out more »

Development of Novel and Emerging Technologies to Support Zebrafish Models for Biomedical Research (R41/R42)

January 5, 2018

Sponsor: National Institutes of Health
Due Date: January 5, 2018 by 5 pm local time of applicant
Award: Money, property, or both to an eligible entity to carry out an approved project or activity. Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Find out more »

Development of Novel and Emerging Technologies to Support Zebrafish Models for Biomedical Research (R43/R44)

January 5, 2018

Sponsor: National Institutes of Health
Due Date: January 5, 2018 by 5 pm local time of applicant
Award: Money, property, or both to an eligible entity to carry out an approved project or activity. Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Find out more »

Medical Research Fellows Program

January 11, 2018

Sponsor: Howard Hughes Medical Institute
Due Date: January 11, 2018
Award: $32,000 stipend for one year and other allowances

Find out more »
July 2018

Cycle 7: NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U01)

July 18, 2018

Sponsor: National Institute of Neurological Disorders and Stroke
Due Date: July 18, 2017
Award: Actual needs; Budgets for these projects will normally remain under $500,000 in direct costs in any given year and fluctuate over the funding period based on the stage of the project.

Find out more »
+ Export Events